Ottawa charter framework as a guide for type 2 diabetes prevention and control in Iran

被引:0
|
作者
Maryam Peimani
Ensieh Nasli-Esfahani
Elham Shakibazadeh
机构
[1] Tehran University of Medical Sciences,Department of Health Education and Promotion, School of Public Health
[2] Tehran University of Medical Sciences,Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute
关键词
Type 2 diabetes; Ottawa charter; Disease prevention; Health care system;
D O I
暂无
中图分类号
学科分类号
摘要
The growth of T2DM in Iran is predicted to be even greater than the global trend. So a new public health movement to effectively prevent and manage T2DM is required more than ever. The solution has lain in the heart of the Ottawa Charter, the first international conference on health promotion more than 30 years ago. The charter contains five useful actions to facilitate the process of diseases prevention and control: 1) building healthy public policy, 2) creating supportive environments, 3) strengthening community action, 4) developing personal skills, and 5) reorienting health care services toward promotion of health. The charter articulates health in all policies and their frameworks. The aim of this review is to examine how the five actions have been implemented in Iran and can serve as a guide to prevent and control diabetes. Several national case studies will be examined to illustrate the challenges facing Iran’s health system. It enables the identification and sharing of best practice between countries.
引用
收藏
页码:255 / 261
页数:6
相关论文
共 50 条
  • [23] Autoimmunity and prevention of type 2 diabetes: the Diabetes Prevention Program (DPP)
    Dabelea, D.
    Ma, Y.
    Knowler, W. C.
    Marcovina, S.
    Saudek, C.
    Arakaki, R.
    White, N. H.
    Kahn, S.
    Haffner, S. M.
    Orchard, T.
    Goldberg, R.
    Hamman, R. F.
    DIABETOLOGIA, 2006, 49 : 192 - 192
  • [25] Personalised prevention of type 2 diabetes
    Wareham, Nicholas J.
    DIABETOLOGIA, 2022, 65 (11) : 1796 - 1803
  • [26] Prevention of type 2 diabetes with metformin
    不详
    DIABETES OBESITY & METABOLISM, 1999, 1 (05): : 304 - 304
  • [27] Prevention of the Type-2-Diabetes
    Stefan, N.
    Fritsche, A.
    Haering, H. -U.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : R57 - R68
  • [28] Prevention of type 2 diabetes: A review
    Hussain, A.
    Claussen, B.
    Ramachandran, A.
    Williams, R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (03) : 317 - 326
  • [29] Gout prevention in type 2 diabetes
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (08): : e505 - e505
  • [30] The Reality of Type 2 Diabetes Prevention
    Kahn, Richard
    Davidson, Mayer B.
    DIABETES CARE, 2014, 37 (04) : 943 - 949